ADAMTS1 and breast carcinoma: ADAMTS1 (ADAM with ThromboSpondin motifs 1), first suggested as an interesting therapeutic target in breast cancer management [37], has been defined several years later as playing a suppressive role in tumor development and was thus rather proposed as facilitating apoptotic and anti-tumor effects of adjuvant factors used in cancer treatment [38].